Consensus NeuroBo Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-03 EDT			5-day change	1st Jan Change
3.78 ^USD	+1.34%		+20.38%	+2.26%

04-17	Sector Update: Health Care Stocks Mixed Wednesday Afternoon	MT
04-17	NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise	MT

e47cff122d1.iqexFbFPU0rxidti6bAzwo9vBh1x-Y5HAYzbfE-TWcY.zOL8T4A_FSe_--8h0ep1pbYwcV5Iq8dwbMP2MX78LqG-3f1UwyYiOJi7tA~ece593000929998dcacc7e8510f7d26e

Ladenburn Thalmann Starts NeuroBo Pharmaceuticals at Buy With $6 Price Target	22-12-07	MT
NEUROBO PHARMACEUTICALS : HC Wainwright Adjusts Price Target on NeuroBo Pharmaceuticals to $16 From $20, Reiterates Buy Rating	21-02-01	MT

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.78 USD

Average target price

36.5 USD

Spread / Average Target

+865.61%

High Price Target

48 USD

Spread / Highest target

+1,169.84%

Low Price Target

25 USD

Spread / Lowest Target

+561.38%

Ladenburg Thalmann
HC Wainwright